Page 44 Advertisements Column 1

Rip It Up, Issue 220, 1 December 1995, Page 44

HAVRIX 1440 SUMMARISED CONSUMER PRODUCT INFORMATION (Hepatitis A Vaccine) The following is a summary of the most important information about HAVRIX 1440. Full Consumer Product Information is provided with the vaccine. If you want to know more about HAVRIX 1440 you should ask your doctor, nurse or pharmacist. It is important to follow your doctor's advice about HAVRIX 1440. WHAT IS HAVRIX 1440? HAVRIX 1440 is a vaccine made using hepatitis A virus which is grown in a laboratory, in cell culture, then killed. HAVRIX 1440 is made without any human blood products. Each vial of the HAVRIX 1440 contains 1440 ELISA units of the killed virus in ImL of a salt solution. HAVRIX 1440 also contains aluminium hydroxide to promote the activity of the vaccine and small amounts of other excipients. WHAT HAVRIX 1440 IS USED FOR AND HOW IT WORKS HAVRIX 1440 is a vaccine used to prevent hepatitis A. The vaccine works by causing your body to produce its own protection (antibodies) against this disease. Hepatitis A is an infectious disease which affects the liver. It is caused by a virus which is usually transmitted from person to person in food and drink or by contact with water or matter contaminated by sewage. Symptoms of hepatitis A begin 3 to 6 weeks after coming into contact with the virus. BEFORE RECEIVING HAVRIX 1440 You should not receive HAVRIX 1440 if: You have had an unusual or allergic reaction to HAVRIX or any of its contents. You have a severe infection with a high temperature. Women who are pregnant, likely to become pregnant or who are breast.feeding an infant should discuss the risks and benefits of vaccination with their doctor. HOW IS IT GIVEN? HAVRIX 1440 is usually given by injection in to the muscle of the upper arm. Two separate doses are needed, the primary dose and a booster dose given 6to 12 months later. SIDE EFFECTS (THIS NOT-A FULL LIST OF THE ADVERSE EVENTS REPORTED FOLLOWING VACCINATION. REACTIONS THAT ARE COMMON OR SERIOUS ARE LISTED) Reactions following vaccination are generally mild and usually do not last for more than a day. The most common _ _ H TM side effects following HAVRIX 1440 vaccination are local reactions around the injection area such as soreness, mild redness, slight swelling and/or hardness at the site. Less common events may LJ lAZ include, headache, fever, tiredness, loss of appetite, or feeing sick. As with all injectable vaccines, there is a very small risk of a serious allergic or anphylactic reaction. Symptoms may include, I I WI I ZA. severe difficulty in breathing or swallowing, generalised hives, swelling of eyes, or face. Distributed in New Zealand by Smith Kline Beecham (NZ) Ltd, PO Box 62-043, Sylvia Park, Auckland 6. Hepatitis A vaccine